Summary
Procter & Gamble Co. (PG) reported a solid third quarter for fiscal year 2026, with net sales increasing by 7% year-over-year to $21.2 billion, driven by a combination of favorable foreign exchange, unit volume growth, and price increases. Net earnings attributable to the company grew 4% to $3.9 billion, resulting in diluted Earnings Per Share (EPS) of $1.63, a 6% increase. The company's performance was broad-based, with all reportable segments showing net sales growth, highlighting the resilience and demand for its diverse product portfolio. Management's focus on productivity savings and strategic pricing initiatives appears to be effectively navigating cost pressures and contributing to profitability.
Financial Highlights
53 data pointsBeta
Financial Statements
Beta
| Revenue | $21.23B |
| Cost of Revenue | $10.72B |
| Gross Profit | $10.51B |
| SG&A Expenses | $5.94B |
| Operating Income | $4.58B |
| Net Income | $3.93B |
| EPS (Basic) | $1.66 |
| EPS (Diluted) | $1.63 |
| Shares Outstanding (Basic) | 2.33B |
| Shares Outstanding (Diluted) | 2.42B |
Key Highlights
- 1Net sales increased 7% to $21.2 billion for the three months ended March 31, 2026, driven by 2% volume growth, 4% favorable foreign exchange, and 1% higher pricing.
- 2Net earnings attributable to Procter & Gamble grew 4% to $3.9 billion.
- 3Diluted EPS increased 6% to $1.63 for the quarter, indicating improved profitability on a per-share basis.
- 4All five reportable segments (Beauty, Grooming, Health Care, Fabric & Home Care, Baby, Feminine & Family Care) demonstrated net sales growth.
- 5The company incurred $198 million in before-tax restructuring costs in the quarter related to its portfolio and productivity plan, impacting gross margin.
- 6Operating cash flow for the nine months ended March 31, 2026, was a strong $14.4 billion.
- 7The Gillette indefinite-lived intangible asset's fair value was noted to exceed its carrying value by greater than 10%, but it remains susceptible to impairment risk due to potential adverse economic conditions.